Back to search
FDAFDA · Food and drugs·Recall number Z-1375-2013

QuietCare. Intended for use in monitoring the environmental conditions and activity (motion) of an individual living in a senior housing community.

Published June 5, 2013 · Recall initiated: April 4, 2013

Summary

FDA records medical device Class II recall Z-1375-2013, published June 5, 2013 and initiated April 4, 2013. Recalling firm: Intel-GE Care Innovations LLC; Status: Terminated; Reported quantity: 1722S; 99 Out of US; Lot: US  QuietCare: QC200403, v.02; QC200403, v.03; QC200403, v.04; QC200405 UK  QuietCare: QCE200403, v.02; QCE200403, v.03. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Customers at 4 facilities reported receiving duplicate alerts using the QuietCare-Networked product.

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Intel-GE Care Innovations LLC
Distributor
US and Great Britain
Lot
US  QuietCare: QC200403, v.02; QC200403, v.03; QC200403, v.04; QC200405 UK  QuietCare: QCE200403, v.02; QCE200403, v.03
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was QuietCare. Intended for use in monitoring the environmental conditions and activity (motion) of an individual living in a senior housing community. recalled?

Yes. FDA published recall Z-1375-2013 on June 5, 2013. Reported hazard: Customers at 4 facilities reported receiving duplicate alerts using the QuietCare-Networked product.

What should I do if I have this product?

Voluntary: Firm initiated · Telephone